Background
==========

Primary hyperparathyroidism (PHPT) is characterised by excess parathyroid hormone (PTH) secretion arising mostly from one or more autonomously functioning parathyroid adenomas (up to 85%), parathyroid hyperplasia (\<15%), and in 1--2% of cases from parathyroid carcinoma ([@bib1]). PHPT with its prevalence of approximately 1:1000 ([@bib2], [@bib3]) is a relatively common condition and, together with hypercalcaemia of malignancy accounts for the majority of clinical presentations of hypercalcaemia. Parathyroidectomy has been considered the only definitive cure, however, watchful waiting with monitoring for the presence of end-organ damage is also warranted in selected cases ([@bib4]). Over last decades, several cases of spontaneous remission of PHPT have been reported and attributed to spontaneous necrosis, haemorrhage and infarction of parathyroid adenoma and this phenomenon has been referred to as 'parathyroid auto-infarction', 'auto-parathyroidectomy' or 'parathyroid apoplexy' ([@bib5], [@bib6], [@bib7], [@bib8], [@bib9]).

In this report we present two cases of spontaneous resolution of PHPT due to parathyroid auto-infarction, one of which was managed surgically and the other one conservatively. We discuss their outcomes, prognosis and the strategy for long-term management of patients with this presentation.

Case \#1, case presentation
===========================

A 51-year-old man was referred to an endocrinologist by his general practitioner for further evaluation and management of suspected PHPT. He had a background of obesity, type 2 diabetes and ischaemic heart disease. His regular medications included metformin, aspirin, atorvastatin and glyceryl trinitrate spray when required. Three months prior to the referral he presented to his GP with pains and paraesthesia affecting left hand leading to a diagnosis of left carpal tunnel syndrome. There was no history of nephrolithiasis or bone fractures.

Case \#1, investigation
=======================

In the clinic, his blood pressure was 145/85 mmHg, height 185 cm, weight 144 kg with a BMI of 43.0 kg/m^2^. His biochemistry at the time of referral showed adjusted (adj.) serum calcium (Ca^2+^) of 3.11 mmol/L (reference range (RR): 2.20--2.60 mmol/L), parathyroid hormone (PTH) 26.9 pmol/L (RR: 1.6--6.9 pmol/L) ([Fig. 1](#fig1){ref-type="fig"}), phosphate 0.49 mmol/L (RR: 0.80--1.50 mmol/L), alkaline phosphatase 95 IU/L (RR: 30--130 IU/L), vitamin D levels of 32.9 nmol/L and the 24-h urine calcium excretion 18.2 mmol (RR: 2.5--7.5 mmol) with urine volume of 2280 mL. The ultrasound (US) of the neck detected a hypoechoic lobulated mass measuring 33 × 19 × 23 mm in keeping with an enlarged right inferior parathyroid gland ([Fig. 2A](#fig2){ref-type="fig"} and [B](#fig2){ref-type="fig"}). The dual scintigraphy with ^99m^Tc sestamibi and ^99^Tc pertechnetate showed a subtle unmatched area in the region of the left inferior posterior thyroid lobe which was suggestive of a left inferior parathyroid adenoma, however.Figure 1Case \#1. Graph showing timeline of adjusted serum Ca^2+^ and PTH levels with annotated times of parathyroid auto-infarction and parathyroidectomy (red arrows). Reference range for adjusted serum Ca^2+^ (2.20--2.60 mmol/L) is annotated with red dotted lines and reference range for PTH (1.6--6.9 pmol/L) is annotated with black dotted lines. Figure 2Case \#1. (A and B) US neck scan prior to parathyroid adenoma auto-infarction (A. long axis, B. short axis). (C and D) US neck scan several weeks after the parathyroid adenoma auto-infarction (C. long axis, D. short axis). (A, B, C and D): Parathyroid adenoma marked by white cross marks, size in left bottom corners). (E) Histopathological specimen of infarcted parathyroid adenoma (H&E, 100×). Haemosiderin deposits and fibrosis can be observed.

Case \#1, treatment
===================

He was subsequently referred for consideration of parathyroidectomy. Four weeks later, at his pre-operative assessment, his adj. Ca^2+^ levels reduced spontaneously to 2.43 mmol/L and PTH reduced to 8.7 pmol/L ([Fig. 1](#fig1){ref-type="fig"}). A repeated US scan showed a dramatic reduction of the lesion size to 17 × 5 × 10 mm ([Fig. 2C](#fig2){ref-type="fig"} and [D](#fig2){ref-type="fig"}). A US-guided aspiration followed and PTH in the aspirate was found to be 84.8 pmol/L confirming parathyroid origin of this lesion. At the same time, his diabetes was noted to be poorly controlled and required initiation of insulin therapy. Given these circumstances, he was initially managed conservatively with regular serum Ca^2+^ and PTH monitoring ([Fig. 1](#fig1){ref-type="fig"}). Seventeen months later, his adj. Ca^2+^ was noted to be elevated again at 2.75 mmol/L, PTH at 9.8 pmol/L and with his diabetes management now optimised, a decision was made to proceed with surgery. Twenty months after the suspected parathyroid auto-infarction, he had an uneventful bilateral neck exploration (due to discordant imaging studies as detailed above) and an enlarged right inferior parathyroid gland was identified and excised. The histopathological report noted increased fibrosis and haemosiderin deposits in the parathyroid gland in keeping with the previously suspected parathyroid haemorrhage and auto-infarction ([Fig. 2E](#fig2){ref-type="fig"}).

Case \#1, outcome and follow-up
===============================

On day 1 after surgery adj. serum Ca^2+^ was recorded at 2.31 mmol/L and PTH levels normalised as well (3.2 pmol/L). At the follow-up appointment 1.5 months after surgery his adj. Ca^2+^ was 2.24 mmol/L, PTH was 6.2 pmol/L, phosphate was 0.65 mmol/L, alkaline phosphatase was 92 IU/L and vitamin D was 36.3 nmol/L and he was continued on calcium and vitamin D supplementation (Adcal D3^®^ 1 tablet BD). Bone densitometry (dual-energy X-ray absorptiometry -- DXA) done 2.5 months after parathyridectomy gave T-scores of +1.4 in lumbar spine, +0.4 in total hip and −2.5 in distal 1/3 of the forearm, respectively. Recommendations to continue with Ca^2+^ and vitamin D supplements were made and he could be discharged to primary care 6 months after the surgery. The serum adj. Ca^2+^ levels continued to be normal 6.5 months after surgery at 2.42 mmol/L (shown as month 27 in [Fig. 1](#fig1){ref-type="fig"}) and 18.5 months after surgery 2.33 mmol/L (approx. month 39 in [Fig. 1](#fig1){ref-type="fig"}).

Case \#2, case presentation
===========================

A 54-year-old lady of Afro-Carribean/mixed ethnic origin presented to Acute Medical Admissions Unit with a 3-month history of lethargy, weight loss and reduced oral intake. She didn't report any significant past medical history and wasn't taking any regular medications. There was no family history of any endocrine condition.

Case \#2, investigation
=======================

On admission, her BP was 127/72 mmHg, height was172 cm, weight was 75.2 kg, BMI was 25.4 kg/m^2^ and her biochemistry showed adj. serum Ca^2+^ of 4.58 mmol/L (RR: 2.20--2.60 mmol/L), PTH at 51.6 pmol/L (RR: 1.6--6.9 pmol/L) ([Fig. 3](#fig3){ref-type="fig"}), phosphate at 0.22 mmol/L (RR: 0.80--1.50 mmol/L), alkaline phosphatase at 167 IU/L (RR: 30--130 IU/L), borderline elevated serum creatinine at 83 µmol/L (RR: 44--80 µmol/L) and non-detectable vitamin D levels (\<12.5 nmol/L) indicating the presence of PHPT with severe hypercalcaemia, hypophosphataemia and severe vitamin D deficiency. A computed tomography (CT) scan of thorax, abdomen and pelvis and the US scan of the neck were done within 48 h of her admission. The CT scan showed a 21 mm large right para-tracheal lesion with low density and of cystic nature ([Fig. 4A](#fig4){ref-type="fig"}). In addition, lucent bone lesions in T5 and T12 vertebrae, left ilium and left acetabulum were reported and subsequent assessment with magnetic resonance imaging (MRI) suggested these represented brown tumours secondary to PHPT. The US scan of the neck detected the presence of a heterogeneous lesion posteriorly and inferiorly to the right lobe of the thyroid with the largest dimension of 22 mm ([Fig. 4B](#fig4){ref-type="fig"}) and with no vascular flow within it. This lesion was identified as a right inferior parathyroid adenoma. US investigation of renal tract did not show any nephrolithiasis or nephrocalcinosis.Figure 3Case \#2. Graph showing timeline of adjusted serum Ca^2+^ and PTH levels. Presumed time of parathyroid auto-infarction is annotated with a red arrow. Reference range for adjusted serum Ca^2+^ (2.20--2.60 mmol/L) is annotated with red dotted lines and reference range for PTH (1.6--6.9 pmol/L) is annotated with black dotted lines. Figure 4Case \#2. (A) CT scan of chest abdomen and pelvis showing a 21 mm large right para-tracheal lesion with low density and of cystic nature (red arrow). (B) US neck scan, short axis, showing a heterogeneous lesion posteriorly and inferiorly to the thyroid (annotated with white cross marks, dimension in left bottom corner). (C and D) T1-weighed MRI imaging of the neck (C. coronal view, D. sagittal view) showing a 44 mm large mostly cystic lesion in the lower neck (red arrows). (E and F) SPECT-CT (E. axial view, F. coronal view) following pertechnetate and MIBI administration identified the auto-infarcted parathyroid adenoma to have very low level of MIBI activity.

Case \#2, treatment
===================

She was treated with intravenous (IV) normal saline infusion, 90 mg of IV pamidronate and was commenced on high-dose vitamin D supplementation (cholecalciferol 40 000 units once weekly for 7 weeks). Following the initial treatment, adj. Ca^2+^ levels dropped significantly and 8 days after admission, she developed symptomatic hypocalcaemia (nadir adj. Ca^2+^ levels: 1.88 mmol/L with PTH at 17.6 pmol/L on day 10 post admission) which necessitated IV calcium administration ([Fig. 3](#fig3){ref-type="fig"}). A subsequent MRI neck with contrast identified a 44 mm large, apparently cystic lesion lying on the deep aspect of the right thyroid lobe; the medial aspect blending with tracheal wall pushing the trachea but with no airway compromise and its inferior aspect bulged into the apex of the right lung without any obvious infiltration ([Fig. 4C](#fig4){ref-type="fig"} and [D](#fig4){ref-type="fig"}). These findings were supportive of the clinical suspicion of parathyroid auto-infarction. Her serum Ca^2+^ levels normalised several days later and she could be discharged home on cholecalciferol 40 000 units once weekly for the total duration of 7 weeks together with Adcal D3^®^ 2 tablets BD (i.e. 6 grams of Ca^2+^ carbonate and 1600 IU of cholecalciferol) daily. PTH levels normalised approximately 6 weeks after admission. She continued to be closely followed up in the endocrine outpatient clinic with initially monthly, later on with less frequent Ca^2+^ and PTH measurements ([Fig. 3](#fig3){ref-type="fig"}). Two months after the event, her vitamin D levels were recorded at 78 nmol/L. A SPECT-CT imaging following application of both MIBI and pertechnetate done 3 months after initial admission demonstrated a soft tissue density inferiorly to right thyroid lobe with very low level of MIBI activity (likely due to its cystic nature) and no pertechnetate uptake, further confirming the aetiology of this lesion as a parathyroid adenoma ([Fig. 4E](#fig4){ref-type="fig"} and [F](#fig4){ref-type="fig"}). At 6 months, the repeat MRI of the spine could not detect brown tumours anymore. At this stage, PTH levels were noted to be elevated again at 7.5 pmol/L, however, with normal adj. Ca^2+^ (2.39 mmol/L) and vitamin D levels (78.9 nmol/L) ([Fig. 3](#fig3){ref-type="fig"}). Similar laboratory findings were recorded at 11 months and at this stage the cystic parathyroid lesion could not be visualised on the US imaging anymore.

Case \#2, outcome and follow-up
===============================

At present, 18 months after the initial event, her adj. Ca^2+^ was recorded at 2.38 mmol/L and PTH at6.8 pmol/L and she has remained asymptomatic.

Discussion
==========

Spontaneous remission of PHPT due to necrosis, haemorrhage and infarction of parathyroid adenoma, the so-called 'parathyroid auto-infarction', 'auto-parathyroidectomy' or 'parathyroid apoplexy' is very rare in clinical practice but has been previously documented in the literature, the first report being published by Norris *et al.* in 1946 ([@bib5]). Since then, more cases have been published ([@bib6], [@bib7], [@bib8], [@bib9]). In 1995, Nylen *et al.* ([@bib6]) reviewed available literature and observed that presentations of parathyroid auto-infarction could be divided into two groups. In one group patients suddenly became normo- or hypocalcaemic and this was sometimes linked with mild neck pain or tenderness. Necrosis, in some cases with evidence of recent or old haemorrhage, was found on histopathological examination. In the other group, patients presented more acutely with severe neck and/or substernal pain and swelling with respiratory distress and dysphonia requiring surgical exploration. Extensive haematoma related to haemorrhage from parathyroid adenoma was found on histopathological examination ([@bib6]). The authors went on to suggest a single unifying pathological process behind these presentations which begins acutely with necrosis and a degree of haemorrhage which determines the clinical presentation. In cases where haemorrhage is less severe, the process subsequently leads to fibrosis and cyst formation. The difference in the degree of haemorrhage was proposed as a defining feature for sub-classification of this disorder into three types: type 1: adenoma with necrosis without haemorrhage, type 2: adenoma with intra-capsular haemorrhage (or evidence thereof) and necrosis and type 3: adenoma with extracapsular haemorrhage ([@bib6]). Parathyroid auto-infarction usually leads to acute and dramatic reduction of Ca^2+^ and PTH levels leading to remission of PHPT, however, in some cases, the decrease in Ca^2+^/PTH is much less pronounced and entirely asymptomatic ([@bib7]). In most cases reported so far, surgical treatment was eventually indicated, with only a few cases reported in which conservative approach with regular clinical and biochemical follow-up was initially chosen. This might be due to contraindications for surgery or patient preference ([@bib8]). In one case, PHPT recurred 7 years after the auto-infarction leading to parathyroidectomy, which was performed 8 years after the index event ([@bib8]). This indicates that the clinical and biochemical surveillance has to be performed long term, perhaps life-long. The clinical observation that parathyroid auto-infarction doesn't lead to a definitive cure may be likely explained by the presence of non-ischaemic adenomatous tissue having a potential to grow resulting in recurrence of hypercalcaemia at some stage.

In our report we describe two cases of spontaneous remission of PHPT due to parathyroid auto-infarction. None of the patients could remember any neck pain or discomfort around the presumed time of the event. Both patients were initially managed conservatively. In case \#1 this was not only due to spontaneous normalisation of serum Ca^2+^, but also due to poorly controlled diabetes that required optimisation before surgery. Hypercalcaemia recurred 17 months later and he eventually underwent bilateral neck exploration 20 months after the index event. The histopathological findings showed fibrosis and haemosiderin deposits in keeping with parathyroid adenoma auto-infarction, type 2 as per Nylen *et al.*'s classification ([@bib6]).

In case \#2 we have continued with conservative management up to present date, i.e. 18 months after the index event. In this case, the dramatic improvement of severe hypercalcaemia leading to symptomatic hypocalcaemia requiring IV Ca^2+^ administration in line with the current Society for Endocrinology Endocrine Emergency Guidance on Management of Acute Hypocalcaemia ([@bib10]). These changes in serum adj. Ca^2+^ levels were observed after administration of pamidronate in the setting of severe vitamin D deficiency. Given this, in addition to a parathyroid auto-infarction, a plausible differential diagnosis to this clinical scenario would be the effect of bisphosphonate in the presence of severe vitamin D deficiency. The timing of these events (nadir Ca^2+^ value on day 10 after pamidronate administration) would be supportive of this. Although it is entirely possible that the above mechanism contributed to the development of symptomatic hypocalcaemia, the dramatic decrease in serum PTH levels, the cystic character of the parathyroid lesion on MRI, and inability to visualise the previously clearly visible lesion on US imaging several months later is strongly suggestive of parathyroid auto-infarction that likely occurred several days after pamidronate infusion. To our knowledge, there is only one case published in the literature linking IV administration of a bisphosphonate with subsequent parathyroid auto-infarction. This report relates to a case of a parathyroid carcinoma arising from parathyroid hyperplasia ([@bib11]). Importantly, we are unaware of any plausible physiological mechanism by which bisphosphonates could cause parathyroid auto-infarction. The widespread use of bisphosphonates versus the rare incidence of parathyroid auto-infarction suggests that bisphosphonate administration in these cases was likely to be coincidental.

In case\#1 we had discordant results in localisation studies of the parathyroid adenoma. The US scan of the neck identified a large R inferior parathyroid adenoma, whereas the dual scintigraphy with ^99m^Tc sestamibi (MIBI) and ^99m^Tc pertechnetate showed a subtle unmatched area in the region of the left inferior posterior thyroid lobe. Thus, the MIBI findings were more subtle than the findings on US imaging and as they could not be confirmed in surgery they clearly represent a false positive finding. Discordant results in various imaging modalities of the parathyroid is a well described phenomenon ([@bib12]). False-positive scintigraphic findings can be caused by a variety of conditions, the most common being solitary thyroid adenoma, followed by benign and malignant lesions of the neck, breast or lung, thymic lesions or reactive lymph nodes ([@bib13]). Although the sensitivity of the ^99m^Tc sestamibi scan is high in patients with solitary parathyroid adenomas, false-negative and -positive results of ^99m^Tc sestamibi scanning are unavoidable. There are several factors that influence scintigrafic detection of parathyroid adenomas. Apart from size (weight), ^99m^Tc sestamibi uptake also depends on the content of mitochondria-rich oxyphil cells, the expression of P-glycoprotein and the perfusion and functional activity of the adenoma ([@bib14]). Although we are unable to provide more details on the histopathological and immunohistochemical analysis of the parathyroid adenoma specimen in case\#1, we assume that the unfavourable properties in relation to the above characteristics have contributed to the fact that, despite its size, it was not picked up on the parathyroid scintigraphy. From clinical perspective, discordant localisation studies should lead to indication of bilateral neck exploration. If at exploration no discrete abnormality can be found at the presumed site of uptake, like in was in our case\#1, this area is left alone.

In relation to the post-operative management in case\#1, the biochemical picture of mild hypophosphataemia at 1.5 months after surgery (0.65 mmol/L, normal RR: 0.80--1.50 mmol/L) and PTH levels of 6.2 pmol/L in the upper end of normal RR (1.6--6.9 pmol/L) were attributed to be secondary to ongoing vitamin D deficiency (36.3 nmol/L). The possibility of persistent mild PHPT (for example due to a second adenoma and discordant localisation studies) after bilateral neck exploration and normal adjusted Ca^2+^ levels was considered as very unlikely and the patient was discharged to primary care.

Lastly, in case\#1 FNA was used to confirm the aetiology of the lesion. The high detected PTH concentration (800 ng/L) was confirmatory of its parathyroid origin. Similarly to case\#1, we considered the use of FNA, but the lesion could not be visualised on subsequent imaging; probably as a result of previous auto-infarction. It has to be noted that FNA does not form part of standard diagnostic workup in cases of suspected PHPT ([@bib4]) and its indication in these circumstances is still a subject of debate. The unusual clinical behaviour of both presented cases, however, raised questions about the aetiology of the detected neck lesions and concerns were raised not to miss an alternative diagnosis (reactive lymph node, lymphoma). Both cases were discussed on the local endocrine multidisciplinary team (MDT) meetings and it was felt that the benefits of establishing the correct diagnosis outweighed the risks linked with the procedure itself including discomfort, pain or bleeding, but mainly the risk of tumour dissemination in cases of confirmed malignancy. The use of FNA under such and similar circumstances is based on our previous experience and has been reported by our group ([@bib15]) as well as others ([@bib16], [@bib17]).

In summary, our current report adds to the already available amount of literature on cases of spontaneous PHPT remission due to parathyroid auto-infarction, provides a discussion on the possible approaches of clinical management and makes the wide readership aware of this rare, but well described phenomenon.
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